Covidien Ltd Introduces Three Access Products for Advanced Minimally Invasive Procedures

NORTH HAVEN, Conn.--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its Surgical Devices business unit has introduced three access products, VersaStep™ Plus 15mm, Visiport™ Plus with fixation and Versaport™ Plus RPF 15mm with fixation. The products are now available in the United States and are scheduled to be launched in other markets over the next several months.

MORE ON THIS TOPIC